ReviewOncolytic virotherapy2015

Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology.

Manuel Ramírez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.